The Best of The Liver Meeting® lets you catch up with what you missed at the meeting and enables you to revisit a session. All of the sessions are presented with audio and synchronized slide presentations.
Vitamin D and Statins
Also See:
Low Vitamin D Not Linked to Bone Density or Liver Fibrosis in HIV/HCV Group
Vitamin D Intakes:What Clinicians Need to Know
What about Vitamin D and HCV ?
No link between vitamin-D levels and cardiovascular mortality in sunny California
December 16, 2010
Michael O'Riordan
round, there is no association between serum levels of vitamin D, parathyroid hormone (which regulates the active metabolite of vitamin D), and cardiovascular mortality, according to the results of a new study [1]. Even after patients were stratified by kidney function, there was no association between serum vitamin-D levels and death from cardiovascular causes, report investigators.To heartwire, lead investigator Dr Simerjot Jassal (University of California, San Diego) noted that previous trials testing whether or not vitamin D is beneficial have provided contradictory results and those that have suggested a benefit were observational in nature."Our study is also observational and therefore not definitive, as a trial of vitamin-D supplementation would be, but I believe it suggests that caution should be exercised before we make vitamin D the next supplement that will cure all our ailments," she said. "We've seen other supplements receive initial positive press only to fail to demonstrate benefit in actual clinical trials."Hot topic with conflicting evidenceIn the article, published in the December 2010 issue of the American Journal of Medicine, the researchers note that vitamin D is a hot topic in cardiovascular medicine these days, as well as in other research fields, generating a lot of public interest for its possible health benefits.
Two recent reviews, reported by heartwire, found no consistent association between vitamin D and cardiovascular disease, however, and earlier this month a comprehensive report from the Institutes of Medicine, also covered by heartwire, concluded that there is "insufficient evidence" to suggest that low levels of vitamin D as well as calcium are associated with a range of chronic diseases, including cardiovascular disease, diabetes, and obesity.25(OH)D is the metabolite that represents the state of vitamin-D sufficiency, and 1,25(OH)2D is the active metabolite regulated by the parathyroid hormone. In terms of mechanisms, explain the authors, these two metabolites are believed to stimulate the secretion and action of insulin, inhibit cellular proliferation, and modulate the inflammatory response associated with atherosclerosis. Low levels of 25(OH)D have also been linked with hypertension, diabetes, and insulin resistance.In this cohort of 1073 adults, the baseline levels of 25(OH)D and 1,25(OH)2D were 42 ng/mL and 29 pg/mL, respectively. Over a median follow-up of 6.8 years, there were 266 deaths, including 111 cardiovascular deaths in individuals with varying kidney function. In an unadjusted analysis, higher levels of 1,25(OH)2D were protective against cardiovascular mortality and higher levels of parathyroid hormone showed a higher risk of cardiovascular death, but after adjustment for age alone or multiple covariates, these associations were no longer statistically significant.In their report, Jassal and colleagues note that patients with chronic kidney disease (CKD), those with an estimated glomerular filtration rate <60 mL/min/1.73 m2, have low levels of 25(OH)D and 1,25(OH)2D and increased levels of parathyroid hormone, and it has been hypothesized that this might explain the link between CKD and cardiovascular disease mortality.
That said, the researchers observed no association between serum vitamin-D levels and cardiovascular mortality when stratifying patients by CKD status.The vitamin-D levels of patients included in this trial would be normal, said Jassal, with 25 (OH)D levels <30>30 ng/mL, there was no difference in cardiovascular mortality, although she notes that just 14% of patients in this trial had levels lower than that "normal" threshold. As a result, they do not rule out that larger disruptions in vitamin D, such as 25(OH)D levels <20 ng/mL, might contribute to an increased risk of cardiovascular mortality."As a practicing general internist, I am cautious in recommending supplementation of any kind to my patients until there is sufficient evidence supporting it," she told heartwire. "In the case of vitamin D, there is clear evidence for benefits in bone health, but in terms of protection against cardiovascular disease, the jury is still out, and I won't recommend it for this indication in my own patients until I see a clinical trial demonstrating benefit with supplementation."
A large National Institutes of Health-sponsored study is currently attempting to determine the role of vitamin D and/or omega-3 fatty-acid supplementation in reducing the risk of cardiovascular disease, stroke, and cancer risk.The Vitamin D and Omega-3 Trial (VITAL) investigators plan to enroll approximately 20 000 patients, including 5000 black individuals, a cohort known to be at higher risk of vitamin-D deficiency.
The Thiazolidinedione Intervention with Vitamin D Evaluation (TIDE) trial comparing rosiglitazone vs pioglitazone also included a vitamin-D-vs-placebo randomization within the study, but that trial has since been placed on "clinical hold" by the Food and Drug Administration.Jassal noted that she would not like patients and physicians to interpret the trial by concluding that vitamin D is not beneficial, but rather that it is not associated with cardiovascular health in patients who already have sufficiently high enough levels. She points out, however, that it can be toxic in very high doses.
The Nutrition Source
Ask the Expert: Vitamin D and Chronic Disease
1. There's been a lot of news lately about vitamin D's role in prevention of cancer, heart disease, and other chronic diseases. What do we know today—and what questions remain?
Vitamin D has a well-established role in maintaining calcium levels in the body and in building strong bones. That's why vitamin D deficiency could increase the risk of osteoporosis. In addition, elderly who don't get enough vitamin D have weaker muscles and are more prone to falls, which could further increase the risk of fractures.
Research over the past few decades has uncovered several new potential roles of vitamin D. Many types of cells in the body can use vitamin D to help regulate critical cellular functions. Vitamin D deficiency could thus lead to several potential problems, such as a weakened immune system and an increased risk of colon and other cancers. Immune dysfunctions may lead to an increased risk of autoimmune diseases including type 1 diabetes and multiple sclerosis, and perhaps to some infectious diseases such as tuberculosis.
Our latest research in the Health Professionals Follow Up Study suggests that vitamin D deficiency may also be linked to heart disease. We checked the vitamin D blood levels in men who were healthy, and then followed them for 10 years. Men who were deficient in vitamin D were twice as likely to have a heart attack as men who had adequate levels of vitamin D. Other scientists have found evidence that vitamin D plays a role in controlling blood pressure and preventing artery damage, and this may explain our findings.
Vitamin D's role in many of these diseases has not been definitively proven through a randomized trial. Nonetheless, an increasing body of human metabolic studies, epidemiologic investigations, and animal studies support an important role of vitamin D that goes far beyond bone health. Vitamin D's complex role is currently the focus of intense scientific scrutiny, and more definitive answers should become available over time.
2. How much vitamin D do I need to get a day to help prevent osteoporosis and perhaps prevent other chronic diseases? How much is too much?
Several randomized trials found that individuals who received vitamin D supplements of 800 IU per day lowered their risk of osteoporosis; trials that provided only 400 IU per day did not show this benefit. It is reasonable to postulate that more than 800 IU per day would provide even more benefit, but this is not proven. A promising analysis of multiple studies suggests that taking 400 to 800 IU of vitamin D each day may lower mortality rates by 7 percent; there are some limitations to this analysis, however, and more research needs to be done before any broad claims can be made about vitamin D supplements and mortality.
Vitamin D intakes greater than 2,000 IU per day have generally not been recommended, and this is probably a conservative upper limit for safety. In fact, recent evidence suggests that doses up to 10,000 IU a day do not cause toxicity—but this does not mean that people should start taking 10,000 IU of vitamin D every day.
A complicating factor in determining how much vitamin D we need to get from diet or supplements is that exposure to sunlight produces vitamin D in the skin, which is then rapidly absorbed in the blood. Thus, a vitamin D intake of 800 IU per day may be too low for a person who rarely gets sun exposure (or for someone living in the north, where vitamin D cannot be made in the late-autumn and winter months). Yet that level of intake may not even be necessary for a person who receives ample sun exposure.
3. Since milk is fortified with vitamin D, should I drink lots of milk to get the benefits of vitamin D? If not, what other foods are good sources of vitamin D? Or can I just get enough vitamin D from the sun?
Milk alone is unlikely to be an adequate source of vitamin D. True, milk is fortified in the U.S. (it is not fortified in most countries). Each glass of fortified milk should contain about 100 IU of vitamin D (but on average, it may contain only 50 IU). So someone would have to drink at least 8 glasses of milk per day to get 800 IU of vitamin D. Moreover, most experts now conclude that 1,000 to 2,000 IU per day of vitamin D may be what we need for optimum health.
Fatty fish is the only good natural source of vitamin D. A 3.5 oz serving of cooked salmon, for example, has 360 IU of vitamin D; 3 oz of canned tuna has 200 IU; and 1 3/4 oz of canned sardines has 250 IU.
Sun exposure can be a good source of vitamin D for some people: For example, in a light-skinned person, one, 30-minute, full body exposure to summer sun at noon triggers the release of about 20,000 IU of vitamin D into the circulation; in a dark-skinned person, that amount of summer sun would create about half as much vitamin D. But one must be very cautious about making recommendations to increase sun exposure solely to increase vitamin D intake. There are downsides to receiving excessive sun exposure, such as skin cancer and premature skin aging.
4. Should people consider taking vitamin D supplements? If so, who might benefit most from supplements?
Because we may need more vitamin D than most people get in typical diets, and because of the potential downsides of excessive sun exposure, supplementation may be warranted. It may turn out that most people may benefit from supplements.
Several groups are at risk for vitamin D deficiency or less-than-adequate intakes-in particular, the elderly, dark-skinned individuals, obese individuals, and those who avoid the sun. People who live in more northern latitudes (such as Boston, Mass., Milwaukee, Wis., or Portland, Ore. ) can only make vitamin D from March through September; supplies stored from summer sun exposure must last for many months, and by late winter, most of these individuals may be deficient.
Although definitive evidence is not available currently, supplements of at least 1,000 to 2,000 IU per day of vitamin D may be warranted; look for supplements that contain vitamin D3 (cholecalciferol), rather than vitamin D2 (ergocalciferol), since vitamin D3 is three to four times more potent than vitamin D2. As always, it is important to discuss use of supplements with your personal health care provider. I suggest not taking more than 2,000 IU per day of vitamin D in supplement form without specific medical reasons until more definitive data are available concerning the benefits and risks. If you fall into one of the groups that are at a higher risk of vitamin D deficiency, ask your doctor to order a blood test for vitamin D, since your doctor may find that you need a larger daily supplement dose, on the order of 3,000-4,000 IU, to achieve adequate blood levels.
Terms of Use
The aim of the Harvard School of Public Health Nutrition Source is to provide timely information on diet and nutrition for clinicians, allied health professionals, and the public. The contents of this Web site are not intended to offer personal medical advice. You should seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Web site. The information does not mention brand names, nor does it endorse any particular products.
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment